MUMBAI The Delhi High Court on Monday granted U.S. pharmaceuticals giant Pfizer Inc's India unit a stay on a government ban on its popular cough syrup Corex, local television channels reported.
The ban on Pfizer's cough syrup was part of a wider notice issued by the government over the weekend ordering prohibition of the sale and manufacture of 344 combination drugs that a panel of experts found posed a risk to humans.
The next hearing by the Delhi High Court on Pfizer's plea is slated for March 21, TV channels said.
(Reporting by Zeba Siddiqui in MUMBAI; Editing by Gopakumar Warrier)
This story has not been edited by Firstpost staff and is generated by auto-feed.
Published Date: Mar 14, 2016 17:58 PM | Updated Date: Mar 14, 2016 17:58 PM